ARK Genomic Revolution ETF
ARKG
513 hedge funds and large institutions have $2.37B invested in ARK Genomic Revolution ETF in 2021 Q2 according to their latest regulatory filings, with 62 funds opening new positions, 206 increasing their positions, 155 reducing their positions, and 60 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 206 | Existing positions reduced: 155
16% more capital inflows, than outflows
Capital inflows: $289M | Capital outflows: $249M
1% more funds holding
Funds holding: 507 → 513 (+6)
3% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 60
0.87% more ownership
Funds ownership: 23.65% → 24.52% (+0.87%)
12% less funds holding in top 10
Funds holding in top 10: 17 → 15 (-2)
44% less call options, than puts
Call options by funds: $456M | Put options by funds: $812M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$49.1M |
| 2 |
Goldman Sachs
New York
|
+$33.7M |
| 3 |
HRT Financial
New York
|
+$30.8M |
| 4 |
Legend Financial Advisors
Pittsburgh,
Pennsylvania
|
+$15.5M |
| 5 |
Jane Street
New York
|
+$12.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$34.7M |
| 2 |
PEAK6
Chicago,
Illinois
|
-$17.9M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$15.9M |
| 4 |
Morgan Stanley
New York
|
-$14M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$11M |
ARKG Hedge Fund Activity: Q2 2021 in Review
513 of the 5,768 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q2 2021, worth a combined $2.37B — up 6.1% from $2.24B a quarter earlier.
Buyers outnumbered sellers: 62 funds opened new ARKG positions and 60 closed out — a net gain of 2 holders — while 206 added to existing stakes and 155 trimmed.
The largest buyer was Bank of America, adding an estimated $49.1M. The largest seller was OMERS Administration Corp, exiting entirely with an estimated $34.7M sold.
- 513 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q2 2021, up from 507 in Q1 2021.
- Funds reported $2.37B of ARK Genomic Revolution ETF stock for Q2 2021, up 6.1% quarter-over-quarter.
- 62 funds opened new ARK Genomic Revolution ETF positions in Q2 2021 and 60 closed out, a net change of +2 holders.
- The largest ARK Genomic Revolution ETF buyer in Q2 2021 was Bank of America, an estimated $49.1M added.
- The largest ARK Genomic Revolution ETF seller in Q2 2021 was OMERS Administration Corp, an estimated $34.7M sold.
Based on aggregated 13F filings for Q2 2021.